ADALIMUMAB-AACF(CF) PEN (2 PK)

Formula & Concentration

ADALIMUMAB-AACF(CF) PEN (2 PK) – adalimumab-aacf 40 mg/0.8 mL subcutaneous pen kit

ADALIMUMAB-AACF(CF) PEN CROHNS – adalimumab-aacf 40 mg/0.8 mL subcutaneous pen kit

Manufacturer

Fresenius Kabi, LLC

Indications

psoriatic arthritis; non-radiographic axial spondyloarthritis; non-infectious uveitis; sarcoidosis; moderate to severe plaque psoriasis; ulcerative colitis; hidradenitis suppurativa; polyarticular juvenile idiopathic arthritis; ankylosing spondylitis; Crohn’s disease; rheumatoid arthritis; oligoarticular juvenile idiopathic arthritis

oligoarticular juvenile idiopathic arthritis; psoriatic arthritis; rheumatoid arthritis; polyarticular juvenile idiopathic arthritis; non-infectious uveitis; hidradenitis suppurativa; ankylosing spondylitis; sarcoidosis; non-radiographic axial spondyloarthritis; moderate to severe plaque psoriasis; ulcerative colitis; Crohn’s disease

Product Options

Package Size

NDC #

Presentation

40 MG/0.8 ML

65219-0612-99

PEN INJECTION KIT

40 MG/0.8 ML

65219-0612-89

PEN INJECTION KIT

Shelf Life and Storage

Fridge (2-8°C)